Ultragenyx Pharmaceutical (RARE) Prepaid Assets (2013 - 2026)

Ultragenyx Pharmaceutical (RARE) has 14 years of Prepaid Assets data on file, last reported at $68.0 million in Q1 2026.

• On a quarterly basis, Prepaid Assets rose 13.63% year-over-year to $68.0 million in Q1 2026; TTM through Mar 2026 was $68.0 million, a 13.63% increase from a year earlier, with the FY2025 full-year figure at $61.0 million, up 52.5% from the prior year.
• Prepaid Assets for Q1 2026 stood at $68.0 million, up from $61.0 million in the prior quarter.
• Over the last five years, Prepaid Assets for RARE reached as high as $77.5 million in Q2 2022 and fell as low as $40.0 million in Q4 2024.
• Historically, Prepaid Assets has averaged $57.6 million across 5 years, with a median of $59.8 million in 2025.
• Across the five-year window, Prepaid Assets slumped 35.15% in 2023 and jumped 52.5% in 2025, its largest moves.
• Year by year, Prepaid Assets stood at $68.9 million in 2022, then slumped by 30.92% to $47.6 million in 2023, then dropped by 15.99% to $40.0 million in 2024, then surged by 52.5% to $61.0 million in 2025, then advanced by 11.48% to $68.0 million in 2026.
• Per Business Quant data, the three most recent Prepaid Assets figures were $68.0 million in Q1 2026, $61.0 million in Q4 2025, and $53.2 million in Q3 2025.